How Surgical Practices Use These Products
Regulatory Notice: ExaVeyra Sciences is a B2B wholesale supplier. The areas below represent practitioner-reported uses and active research fields, not efficacy claims or treatment indications. No product sold by ExaVeyra Sciences is FDA-approved for treating any condition. All clinical decisions rest with the licensed practitioner.
Licensed surgeons and post-operative care teams are incorporating regenerative biologics into recovery protocols across a range of surgical specialties. ExaVeyra supplies the products — clinical decisions and patient care rest entirely with your licensed team.
MSC-derived exosomes carry signaling cargo that researchers are studying for roles in tissue repair and wound closure — relevant across general surgery, plastics, and orthopedic contexts.
The immunomodulatory properties of MSC-derived exosomes are an active area of research for reducing post-surgical inflammatory burden and supporting tissue homeostasis.
Exosome applications in post-surgical scar modulation are being explored in plastic and reconstructive surgery contexts, with research focusing on fibroblast signaling and collagen remodeling.
Following joint replacement, arthroscopy, or spinal procedures, practitioners are studying exosome adjuncts for cartilage and soft tissue repair signaling support.
In plastic and reconstructive surgery, exosomes are being investigated for flap viability support, tissue integration, and recovery enhancement following significant reconstructive procedures.
Bioactive peptides targeting tissue integrity, collagen synthesis, and cellular repair used as adjuncts in comprehensive post-surgical recovery protocols.
Important: ExaVeyra Sciences does not make clinical efficacy claims. All applications listed above represent areas of active scientific research and practitioner use. Protocol design, patient selection, and clinical application are the responsibility of the licensed practitioner.
Built for Clinical Record-Keeping
Surgical practices operate under rigorous documentation requirements. Every ExaVeyra shipment is designed to integrate with clinical records and compliance workflows.
Particle concentration, size distribution, sterility, mycoplasma, endotoxin — fully documented per lot.
Every shipment carries a unique lot number traceable back to manufacturing and QC records.
Mandatory sterility and mycoplasma testing on every production lot before release.
Temperature monitoring and cold-chain packaging validation documentation included with each delivery.
Recommended for Surgical Recovery Practices
All products require NPI verification and approved wholesale account. COA, sterility testing, and lot tracking documentation provided with every order.
MSC-Derived Exosomes
cGMP-grade exosomes derived from umbilical cord and bone marrow MSCs. NTA-characterized for particle concentration and size. Sterility tested, COA included with every lot.
Bioactive Peptides
Bioactive peptides supplied for licensed practitioner use in post-surgical recovery programs. Sourced to cGMP standards with full documentation.
PRP Preparation Kits
Closed-system PRP kits for in-office platelet-rich plasma preparation. Used by surgical practices offering autologous biologic adjuncts in post-operative care.
What Sets Our Supply Chain Apart
NPI-Verified Access Only
We verify every account. Products are supplied exclusively to licensed medical professionals with confirmed NPI numbers — no exceptions.
cGMP Manufacturing
All exosomes are manufactured in cGMP-compliant facilities with documented quality controls covering particle size, concentration, sterility, and identity.
Full COA Documentation
Every lot ships with a Certificate of Analysis covering particle concentration, sterility, mycoplasma, endotoxin, and identity markers — designed for clinical record integration.
Cold-Chain Validated
Temperature-controlled packaging and validated cold-chain shipping protocols maintain product integrity from our facility to your clinic.
503A/503B Compliance Awareness
Our supply team understands the regulatory environment around compounding and can guide practices on compliant procurement pathways.
Miami-Based, Nationwide
Headquartered in Miami, FL. We ship to licensed practices across the United States with established cold-chain logistics partnerships.
Questions from Surgical Practices
What regenerative products does ExaVeyra offer for post-surgical recovery?+
ExaVeyra offers cGMP MSC-derived exosomes (umbilical cord and bone marrow sources) and bioactive peptides for licensed surgical practices and post-operative recovery programs. All products ship with a Certificate of Analysis and require NPI verification for wholesale access.
How are exosomes used in post-surgical recovery protocols?+
Licensed surgeons and post-operative care practitioners are exploring MSC-derived exosomes as adjuncts in post-operative care protocols. ExaVeyra does not make clinical efficacy claims; protocol design and patient selection rest entirely with the licensed practitioner.
Are exosomes safe to use in post-surgical patients?+
ExaVeyra exosomes are manufactured in cGMP-compliant facilities and tested for sterility, mycoplasma, and endotoxins. Safety assessment for specific patient populations and post-surgical contexts is the clinical responsibility of the licensed practitioner. We supply documentation to support informed clinical decision-making.
What is the difference between exosomes and standard wound care biologics?+
Traditional wound care biologics often include growth factors, skin substitutes, or platelet-derived products. MSC-derived exosomes represent a newer class of biologic carrying a complex cargo of proteins, lipids, and microRNAs that may influence multiple cellular repair pathways simultaneously. Research in this area is active and growing.
What documentation is included with exosome orders for surgical practices?+
Every shipment includes a Certificate of Analysis (COA) covering particle concentration, sterility, mycoplasma, endotoxin testing, and identity markers, along with lot tracking numbers and cold-chain shipping validation. Documentation is designed to support clinical records and compliance requirements.